Healthcare Services stock kpis
Want to see HCSG full AI Analyst Report?
Revenue By Segment
Healthcare Services reported revenue by segment of $479.60M in Q3 2026, up 1.9% from Q2 2026 and up 3.3% year over year. This is the highest value since 2021.
Examines revenue contributions from different business segments, indicating which areas drive growth and where the company might focus future expansion efforts.
The latest quarter implies a dramatic segment mix reversal: Dietary drops sharply while Environmental Services surges, but management’s earnings commentary reports the opposite—Dietary at $262.4 million and Environmental at $217.2 million—suggesting the chart labels may be swapped. Underlying momentum remains positive, with both businesses benefiting from client wins and retention. NEXDINE should add a meaningful new growth engine, supporting management’s upgraded 2027 outlook for low-double-digit revenue growth, though integration costs and acquisition-related loss of interest income may temper near-term benefits.
HCSG Revenue By Segment
| Period | Dietary | Environmental Services | Total |
|---|---|---|---|
| Q3 2026Sep 30, 2026 | $262.40M | $217.20M | $479.60M |
| Q2 2026Jun 30, 2026 | $257.60M | $213.20M | $470.81M |
| Q1 2026Mar 31, 2026 | $254.51M | $208.25M | $462.77M |
| Q4 2025Dec 31, 2025 | $255.87M | $210.81M | $466.68M |
| Q3 2025Sep 30, 2025 | $252.55M | $211.79M | $464.34M |
| Q2 2025Jun 30, 2025 | $252.75M | $205.74M | $458.49M |
| Q1 2025Mar 31, 2025 | $251.32M | $196.34M | $447.66M |
| Q4 2024Dec 31, 2024 | $245.11M | $192.70M | $437.81M |
| Q3 2024Sep 30, 2024 | $237.05M | $191.10M | $428.15M |
| Q2 2024Jun 30, 2024 | $235.28M | $191.01M | $426.29M |
| Q1 2024Mar 31, 2024 | $232.87M | $190.56M | $423.43M |
| Q4 2023Dec 31, 2023 | $232.44M | $191.40M | $423.84M |
| Q3 2023Sep 30, 2023 | $220.47M | $190.92M | $411.39M |
| Q2 2023Jun 30, 2023 | $228.11M | $190.82M | $418.93M |
| Q1 2023Mar 31, 2023 | $223.71M | $193.52M | $417.23M |
| Q4 2022Dec 31, 2022 | $226.04M | $197.98M | $424.02M |
| Q3 2022Sep 30, 2022 | $217.55M | $196.94M | $414.49M |
| Q2 2022Jun 30, 2022 | $225.79M | $199.06M | $424.86M |
| Q1 2022Mar 31, 2022 | $225.11M | $201.70M | $426.81M |
| Q4 2021Dec 31, 2021 | $220.40M | $200.05M | $420.45M |
| Q3 2021Sep 30, 2021 | $212.21M | $203.38M | $415.59M |
| Q2 2021Jun 30, 2021 | $195.33M | $202.84M | $398.17M |
| Q1 2021Mar 31, 2021 | $192.69M | $215.06M | $407.75M |

